Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bukreyev

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Cell Host & Microbe|April 23, 2020
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other AntibodiesPhilipp A Ilinykh, Kai Huang, Rodrigo I Santos, et al.
Plos Pathogens|May 18, 2022
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER regionClara T Schoeder, Pavlo Gilchuk, Amandeep K Sangha, et al.
Nature Communications|July 30, 2024
Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccineIvan V Kuzmin, Ruben Soto Acosta, Layne Pruitt, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Science Advances|September 22, 2023
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infectionGabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, et al.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Nature Structural & Molecular Biology|March 6, 2019
Structural basis of broad ebolavirus neutralization by a human survivor antibodyBrandyn R West, Anna Z Wec, Crystal L Moyer, et al.
Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Viruses|May 12, 2017
Implementation of Objective PASC-Derived Taxon Demarcation Criteria for Official Classification of FilovirusesYīmíng Bào, Gaya K Amarasinghe, Christopher F Basler, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Cell Host & Microbe|April 23, 2020
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other AntibodiesPhilipp A Ilinykh, Kai Huang, Rodrigo I Santos, et al.
Plos Pathogens|May 18, 2022
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER regionClara T Schoeder, Pavlo Gilchuk, Amandeep K Sangha, et al.
Nature Communications|July 30, 2024
Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccineIvan V Kuzmin, Ruben Soto Acosta, Layne Pruitt, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Science Advances|September 22, 2023
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infectionGabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, et al.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Nature Structural & Molecular Biology|March 6, 2019
Structural basis of broad ebolavirus neutralization by a human survivor antibodyBrandyn R West, Anna Z Wec, Crystal L Moyer, et al.
Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Viruses|May 12, 2017
Implementation of Objective PASC-Derived Taxon Demarcation Criteria for Official Classification of FilovirusesYīmíng Bào, Gaya K Amarasinghe, Christopher F Basler, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Pageof 17